American Association of Clinical Endocrinologists

Growth hormone levels predict postsurgical acromegaly remission

Posted on: 16/05/2014 - 14:20

Elevated growth hormone levels had a negative impact on remission in acromegaly patients undergoing transsphenoidal adenomectomies, researchers from Emory University in Atlanta concluded after a...

Field of Interest: Endocrinology

Type: News Item

VIDEO: HbA1c focus of diabetes education program

Posted on: 15/05/2014 - 18:35

LAS VEGAS – In its fourth year, the Blood Sugar Basics program, which is the American College of Endocrinology and Merck’s diabetes education program, is turning its attention to hemoglobin...

Field of Interest: Endocrinology

Type: News Item

Canagliflozin effects include weight loss in phase III placebo-controlled trial

Posted on: 15/05/2014 - 17:45

Treatment with canagliflozin was associated with significant weight loss as well as improvements in glycemic control, when compared with placebo in a 26-week, phase III study of nearly 600...

Field of Interest: Cardiology

Type: News Item

20-study analysis finds no MACE increase with saxagliptin

Posted on: 15/05/2014 - 17:45

Treatment with saxagliptin was not associated with an increased risk of major adverse cardiovascular events or heart failure in a pooled analysis of 20 studies of patients with type 2 diabetes.<br...

Field of Interest: Endocrinology

Type: News Item

Empagliflozin improves glycemia, blood pressure in type 2 diabetes study

Posted on: 15/05/2014 - 17:45

Treatment with empagliflozin, an investigational sodium-glucose cotransporter 2 (SGLT2) inhibitor, was associated with benefits for blood pressure as well as glycemic control in a 3-month study of...

Field of Interest: Endocrinology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Growth hormone levels predict postsurgical acromegaly remission

VIDEO: HbA1c focus of diabetes education program

Canagliflozin effects include weight loss in phase III placebo-controlled trial

20-study analysis finds no MACE increase with saxagliptin

Empagliflozin improves glycemia, blood pressure in type 2 diabetes study

Newsletters

Latest Newsletters